Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Chubb
Moodys
US Army
Fish and Richardson
McKinsey
Argus Health
Julphar
Boehringer Ingelheim

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020796

« Back to Dashboard

NDA 020796 describes COMTAN, which is a drug marketed by Orion Pharma and is included in one NDA. It is available from twelve suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the COMTAN profile page.

The generic ingredient in COMTAN is entacapone. There are nineteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the entacapone profile page.
Summary for 020796
Tradename:COMTAN
Applicant:Orion Pharma
Ingredient:entacapone
Patents:1
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020796
Suppliers and Packaging for NDA: 020796
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COMTAN entacapone TABLET;ORAL 020796 NDA Novartis Pharmaceuticals Corporation 0078-0327 N 0078-0327-05
COMTAN entacapone TABLET;ORAL 020796 NDA AUTHORIZED GENERIC KAISER FOUNDATION HOSPITALS 0179-0166 N 0179-0166-70

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Oct 19, 1999TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Sep 14, 2018Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PARKINSON'S DISEASE

Expired US Patents for NDA 020796

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Sign Up ➤ Sign Up
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Sign Up ➤ Sign Up
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Sign Up ➤ Sign Up
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Moodys
Express Scripts
Argus Health
Queensland Health
QuintilesIMS
Dow
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot